Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Stopped Study was never initiated due to company decision. No study subjects were ever enrolled or treated.

Conditions

• Glaucoma
• Ocular Hypertension

Interventions

• DRUG: dorzolamide hydrochloride 2.0%/brimonidine tartrate 0.2%/timolol 0.5% ophthalmic solution

Sponsor

Allergan